[{"Assets_0_FY_USD":2071800000.0,"CommonStockSharesOutstanding_0_FY_shares":46681798.0,"EarningsPerShareBasic_4_FY_USD":0.85,"EarningsPerShareDiluted_4_FY_USD":0.85,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":188800000.0,"NetIncomeLoss_4_FY_USD":39800000.0,"StockholdersEquity_0_FY_USD":1102500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":47000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":46600000.0,"Ticker":"AVNS","CIK":"1606498","name":"HALYARD HEALTH, INC.","OfficialName":"Avanos Medical Inc. Common Stock","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1515595188.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"nan","filed":"20170227"}]